Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property

• 主要な著者: Guy A. Higgins (著者), Nicole K. Carroll (著者), Matt Brown (著者), Cam MacMillan (著者), Leo B. Silenieks (著者), Sandy Thevarkunnel (著者), Julia Izhakova (著者), Lilia Magomedova (著者), Ines DeLannoy (著者), Edward M. Sellers (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2021-02-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Long term benefits following short-term administration of high psychedelic doses of serotonergic and dissociative hallucinogens, typified by psilocybin and ketamine respectively, support their potential as treatments for psychiatric conditions such as major depressive disorder. The high psychedelic...